These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 16504414)

  • 1. Atrial fibrillation in athletes: implicit literature-based connections suggest that overtraining and subsequent inflammation may be a contributory mechanism.
    Swanson DR
    Med Hypotheses; 2006; 66(6):1085-92. PubMed ID: 16504414
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atrial fibrillation in endurance-trained athletes.
    Sorokin AV; Araujo CG; Zweibel S; Thompson PD
    Br J Sports Med; 2011 Mar; 45(3):185-8. PubMed ID: 19654095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial fibrillation in athletes.
    Turagam MK; Velagapudi P; Kocheril AG
    Am J Cardiol; 2012 Jan; 109(2):296-302. PubMed ID: 22019138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between inflammation and atrial fibrillation in patients with isolated rheumatic mitral stenosis.
    Selcuk MT; Selcuk H; Maden O; Temizhan A; Aksu T; Dogan M; Sasmaz A
    J Heart Valve Dis; 2007 Sep; 16(5):468-74. PubMed ID: 17944117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and atrial fibrillation: is Chlamydia pneumoniae a candidate pathogen of atrial fibrillation?
    Tang RB; Dong JZ; Liu XP; Ma CS
    Med Hypotheses; 2006; 67(3):462-6. PubMed ID: 16793213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atrial fibrillation and atrial flutter in athletes.
    Calvo N; Brugada J; Sitges M; Mont L
    Br J Sports Med; 2012 Nov; 46 Suppl 1():i37-43. PubMed ID: 23097477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased prevalence of atrial fibrillation in the endurance athlete: potential mechanisms and sport specificity.
    Olshansky B; Sullivan R
    Phys Sportsmed; 2014 Feb; 42(1):45-51. PubMed ID: 24565821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inflammatory markers according to types of atrial fibrillation.
    Gedikli O; Dogan A; Altuntas I; Altinbas A; Ozaydin M; Akturk O; Acar G
    Int J Cardiol; 2007 Aug; 120(2):193-7. PubMed ID: 17240468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of C-reactive protein to long-term risk of recurrence of atrial fibrillation after electrical cardioversion.
    Loricchio ML; Cianfrocca C; Pasceri V; Bianconi L; Auriti A; Calo L; Lamberti F; Castro A; Pandozi C; Palamara A; Santini M
    Am J Cardiol; 2007 May; 99(10):1421-4. PubMed ID: 17493472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of the post-cardioversion time course of hs-CRP levels in clarifying the relationship between inflammation and persistence of atrial fibrillation.
    Kallergis EM; Manios EG; Kanoupakis EM; Mavrakis HE; Kolyvaki SG; Lyrarakis GM; Chlouverakis GI; Vardas PE
    Heart; 2008 Feb; 94(2):200-4. PubMed ID: 17575330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there a link between atrial fibrillation and certain bacterial infections?
    Andrew P; Montenero AS
    J Cardiovasc Med (Hagerstown); 2007 Dec; 8(12):990-6. PubMed ID: 18163009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationship between C-reactive protein level and early recurrence of atrial fibrillation after electrical cardioversion].
    Zarauza J; Rodríguez Lera MJ; Fariñas Alvarez C; Hernando JP; Ceballos B; Gutiérrez B; Pérez J; Cuesta JM
    Rev Esp Cardiol; 2006 Feb; 59(2):125-9. PubMed ID: 16540033
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atrial fibrillation and CHADS2 risk factors are associated with highly sensitive C-reactive protein incrementally and independently.
    Crandall MA; Horne BD; Day JD; Anderson JL; Muhlestein JB; Crandall BG; Weiss JP; Lappé DL; Bunch TJ
    Pacing Clin Electrophysiol; 2009 May; 32(5):648-52. PubMed ID: 19422587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atrial fibrillation in athletes.
    Farrar MW; Bogart DB; Chapman SS; Rigden LB
    Mo Med; 2006; 103(3):297-301. PubMed ID: 16910441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Atrial fibrillation in athletes].
    Komorowska A; Ptaszyński P; Rosiak M; Krzysztof Wranicz J; Cygankiewicz I
    Pol Merkur Lekarski; 2014 Nov; 37(221):292-6. PubMed ID: 25546992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Source of inflammatory markers in patients with atrial fibrillation.
    Liuba I; Ahlmroth H; Jonasson L; Englund A; Jönsson A; Säfström K; Walfridsson H
    Europace; 2008 Jul; 10(7):848-53. PubMed ID: 18523031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of Atrial Fibrillation in the Athlete.
    Raju H; Kalman JM
    Heart Lung Circ; 2018 Sep; 27(9):1086-1092. PubMed ID: 29861323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New-onset atrial fibrillation in bacteremia is not associated with C-reactive protein, but is an indicator of increased mortality during hospitalization.
    Kindem IA; Reindal EK; Wester AL; Blaasaas KG; Atar D
    Cardiology; 2008; 111(3):171-80. PubMed ID: 18434721
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relation of C-reactive protein and new-onset atrial fibrillation in patients with acute myocardial infarction.
    Aronson D; Boulos M; Suleiman A; Bidoosi S; Agmon Y; Kapeliovich M; Beyar R; Markiewicz W; Hammerman H; Suleiman M
    Am J Cardiol; 2007 Sep; 100(5):753-7. PubMed ID: 17719315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.